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Objectives. The aim of this study was to assess the potential
acute benefit of multisite cardiac pacing with optimized atrioven-
tricular synchrony and simultaneous biventricular pacing in
patients with drug-refractory congestive heart failure (CHF).
Background. Prognosis and quality of life in severe CHF are
poor. Various nonpharmacological therapies have been evaluated
but are restricted in their effectiveness and applications. In the
early 1990s, dual chamber pacing (DDD) pacing was proposed as
primary treatment of refractory CHF but results were controver-
sial. Recently, tests to evaluate the effect of simultaneous pacing of
both ventricles have elicited a significant improvement of cardiac
performance.
Methods. Acute hemodynamic study was conducted in 18
patients with severe CHF (New York Heart Association class III
and IV) and major intraventricular conduction block (IVCB)
(QRS duration 5 170 6 37 ms). Using a Swan-Ganz catheter,
pulmonary artery pressure, pulmonary capillary wedge pressure
(PCWP) and cardiac index (CI) were measured in different pacing
configurations: atrial pacing (AAI) mode, used as reference,
single-site right ventricular DDD pacing and biventricular pacing
with the right ventricular lead placed either at the apex or at the
outflow tract.
Results. The CI was significantly increased by biventricular
pacing in comparison with AAI or right ventricular (RV). DDD
pacing (2.7 6 0.7 vs. 2 6 0.5 and 2.4 6 0.6 l/min/m2, p < 0.001).
The PCWP also decreased significantly during biventricular pac-
ing, compared with AAI (22 6 8 vs. 27 6 9 mm Hg; p < 0.001).
Conclusions. This acute hemodynamic study demonstrated that
biventricular DDD pacing may significantly improve cardiac
performance in patients with IVCB and with severe heart failure,
in comparison with intrinsic conduction and single-site RV DDD
pacing.
(J Am Coll Cardiol 1998;32:1825–31)
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Despite advances made in drug treatment and the introduction
of angiotensin-converting enzyme (ACE) inhibitors in partic-
ular, the prognosis of New York Heart Association (NYHA)
class III and IV chronic congestive heart failure (CHF) is still
pejorative (1) and quality of life is very poor. Various nonphar-
macological treatments have been used in an attempt to
alleviate that fact. Heart transplantation remains the gold
standard although it is restricted by the chronic lack of
available grafts. Implantable left ventricular assistance devices
are only at the evaluation stage. Long-term results on cardio-
myoplasty are still controversial. It was in such a dismal context
that pacing therapy in the early 1990s was proposed as a
primary treatment of drug-refractory heart failure in patients
who did not present with any conventional indication of
permanent cardiac pacing (2). The encouraging results from
the first uncontrolled studies by short atrioventricular delay
dual chamber pacing (DDD) pacing (2,3), however, were not
confirmed by later studies (4,5), although they suggested that
certain individuals could be potential responders. The evi-
dence of major atrioventricular (AV) asynchrony in the left
heart, as indicated in particular by a long PR interval on
surface electrocardiogram (ECG) (6), could help in selecting
those patients. However, the frequent failure of that treatment
is perhaps due to the fact that DDD pacing at a single site in
the right ventricle (RV), usually the apex, aggravates or is at
least unable to correct the major left ventricular activation,
contraction and relaxation asynchrony characterizing a large
number of patients with chronic left ventricular (LV) systolic
dysfunction (7–9). Some clinical case reports suggest that
simultaneous pacing of both ventricles may contribute to
correcting this asynchrony and may significantly improve car-
diac performance.
The aim of this acute hemodynamic study was to assess the
potential benefit of biventricular DDD pacing by comparison
with no ventricular pacing and with conventional single-site
RV DDD pacing in patients with normal sinus rhythm, drug-
refractory CHF related to dilated cardiomyopathy and surface
ECG evidence of major intraventricular conduction block.
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Methods
Inclusion criteria. The following criteria were required for
inclusion in the study:
Age .18 and ,80 years
Stable sinus rhythm
Severe CHF, as defined by:
NYHA class III or IV, in stable condition for at least 4
weeks despite medical treatment including at least di-
uretics and ACE inhibitors at doses individually opti-
mized for each patient
Left ventricular ejection fraction (LVEF) as assessed by
echocardiography, or radionuclide angiography #35%
Left ventricular dilatation defined by an echocardiographic
end-diastole diameter $60 mm
Intraventricular conduction blocks defined by QRS dura-
tion $120 ms, as measured from three leads at least on
surface ECG in spontaneous sinus rhythm
Ischemic or idiopathic cardiomyopathy according the re-
sults of previous coronary angiography
Written informed consent approved by our institutional
Ethics Committee.
Exclusion criteria. The following criteria were required for
exclusion in the study:
High degree (2nd or 3rd) AV block
Suspected acute myocarditis
Significant and correctable valvular heart disease
Acute coronary syndrome less than 3 months before
Percutaneous coronary angioplasty or coronary artery by-
pass grafts within the preceding 12 months
Study protocol. Temporary cardiac pacing. Four 6F quad-
ripolar electrode catheters (Bard Electrophysiology, CR Bard,
Billerica, Massachusetts) were inserted through the femoral or
the subclavian vein and placed at (Fig. 1):
the right atrial appendage to pace the right atrium (RA)
the mid or distal part of the coronary sinus (CS) to pace the
left atrium (LA)
the RV apex (RVA) and the RV outflow tract (RVOT)
alternatively to pace the right ventricle
a lateral or posterolateral vein over the LV free wall
through the CS to pace the left ventricle.
Electrode catheters were connected to an external DDD
pacemaker (Biotronik GmbH and Co., Berlin, Germany). To
eliminate any potential influence of individual intra- and
interatrial conduction time on left atrial systole and on left AV
synchrony, the two atria were paced simultaneously by con-
necting the distal electrode of the coronary sinus lead to the
negative pole of the atrial entry of the external pacemaker and
the distal electrode of the right atrial lead to the positive pole.
The energy delivered was programmed as twice the biatrial
pacing threshold.
To eliminate any variation of heart rate, we permanently
overdrive the intrinsic atrial rate with a pacing rate (which was
kept constant all along the study) of 10 beats per minute above
spontaneous sinus rate in each patient. During DDD pacing,
AV delay in each patient was set to the longest programmable
value, ensuring complete and permanent ventricular (or biven-
tricular) capture.
Biventricular pacing was obtained by connecting the distal
electrode of the LV lead to the negative pole of the ventricular
entry and the distal electrode of the RV lead (placed alterna-
tively at RVA and RVOT) to the positive pole. The energy
delivered was programmed to be twice the biventricular pacing
threshold.
Abbreviations and Acronyms
AVD 5 atrioventricular delay
CHF 5 congestive heart failure
CI 5 cardiac index
LV 5 left ventricular
LVEF 5 left ventricular ejection fraction
PAP 5 pulmonary arterial pressure
PCWP 5 pulmonary capillary wedge pressure
RV 5 right ventricular
RVA 5 right ventricular apex
RVOT 5 right ventricular outflow tract
Figure 1. Periprocedural X-ray frontal view showing the position of
the intracardiac leads. RAA 5 right atrial appendage; CS-LA 5
coronary sinus for left atrial pacing; LV 5 left ventricle through a
lateral vein over the LV-free wall; RVA 5 right ventricular apex;
RPA 5 right pulmonary artery (Swan-Ganz catheter).
1826 LECLERCQ ET AL. JACC Vol. 32, No. 7
BIVENTRICULAR PACING IN END-STAGE HEART FAILURE PATIENTS December 1998:1825–31
Capture of both atria and both ventricles was confirmed by
a significant shortening in paced P/QRS duration with typical
modifications of morphology and axis on the surface ECG.
Three different pacing modes were compared in random
order in each patient:
biatrial pacing in the atrial pacing (AAI) mode, serving as
the reference
optimal single RV DDD pacing: after assessing the two
different RV pacing sites, RV apex (RVA) and RVOT,
the optimal RV DDD mode was defined as the one
providing the highest value of cardiac index (CI) in each
patient
optimal biventricular RV DDD pacing: after assessing two
different combinations of simultaneous biventricular
pacing, RV apex 1 LV and RVOT 1 LV, the optimal
biventricular DDD mode was defined as the one pro-
ducing the shortest duration of the paced QRS complex
on surface ECG, in each patient.
Hemodynamic study. Patients were examined while in a
supine, nonsedative, postabsorptive state. A thermodilution
Swan-Ganz catheter (Baxter Healthcare, Edwards Critical-
Care Division, Irvine, California) was inserted via the jugular
vein and positioned in the pulmonary artery so that pulmonary
capillary wedge pressure (PCWP) recordings were obtained
upon balloon inflation. Cardiac output was recorded in tripli-
cate or until three recordings within 10% of each other were
obtained. Blood pressure was measured by cuff sphygmoma-
nometer.
Pressures and CO were measured 10 min after the initiation
of each new pacing mode. Pressure curves were analyzed by
two blinded independent observers.
Statistical analysis. Each patient was his or her own
control. Data are presented as means 6 SD. A repeated
measures analysis of variance (ANOVA) was used to compare
hemodynamic data at baseline (AAI mode) and during single-
site DDD pacing and during biventricular DDD pacing mode.
The Wilks’ lambda statistic test was used to determine whether
the modes differed and the method of contrasts with the
resulting F-ratio to compare the modes pairwise. To adjust for
the fact that we make three comparisons, a nominal p value of
0.5/3 (50.0167) was used (Bonferroni method).
Results
Patients’ data (Table 1). Eighteen patients, mean age 65
years, were included in the study. Most of them (14/18 5 78%)
were in NYHA class IV; the 4 others were in class III. All
patients were treated by ACE inhibitors and diuretics at the
maximal tolerated doses. Digoxin was also prescribed in 60%
of cases. Mean LVEF was 19 6 4.5%. The LV systolic
dysfunction was of ischemic origin in only 2 cases, 14 patients
had an idiopathic dilated cardiomyopathy (DCM) with normal
or coronary angiograms, 1 patient had a corrected valvular
heart disease and the remaining patient had a sarcoı¨dosis.
During normal sinus rhythm, the average PR interval was
slightly prolonged (221 6 51 ms). The mean QRS duration was
170 6 37 ms with left bundle branch block morphology in all
cases and left axis deviation (.230°) in 14 patients.
The severity of heart failure was confirmed by hemodynam-
ics in baseline conditions (AAI pacing mode). Cardiac index
(CI) on average was 2 6 0.4 l/mn/m2. Mean pulmonary arterial
pressure (PAP), PCWP, and V-wave values were 40 6 11, 27 6
9 and 33 6 11 mm Hg, respectively.
Influence of the pacing mode on QRS duration (Table 2).
Single-site RV-DDD pacing significantly increased QRS dura-
tion by comparison with AAI pacing (p , .01). Conversely,
biventricular DDD significantly decreased QRS duration by
comparison with either the reference mode (p , .01) or
RV-DDD pacing modes (Fig. 2).
Hemodynamic results. In the 15 patients in whom both RV
pacing sites were evaluated, the “optimal” performance in
single-site RV-DDD pacing was observed in 9 cases when the
RV lead was placed at the outflow tract and in 6 cases when the
lead was placed at the apex. In three patients, only one site was
tested (RVA in one and RVOT in two [patients 6, 9 and 16]).
The AV delay did not significantly differ between these two
configurations. With DDD biventricular pacing, the “optimal”
configuration was LV 1 RVOT in 11 patients and LV 1 RVA
in the other 7 patients. In nine patients, the location of the RV
lead was different when comparing single-site RV DDD pacing
and biventricular DDD pacing.
RV-DDD pacing versus baseline (AAI mode) (Tables 2 and
3). The RV-DDD pacing mode induced a statistically signifi-
cant increase in CI (p , 0.01), on average 118.5% in
comparison with baseline (2.4 6 0.6 and 2 6 0.4 l/mn/m2,
respectively).
Mean pulmonary capillary wedge pressure (PCWP) was
significantly decreased in RV-DDD pacing mode, with a mean
reduction of 11% (24 6 8 vs. 27 6 9 mm Hg, respectively).
The same observation was found concerning the V-wave,
with a mean reduction of 7% (p , 0.01).
Table 1. Patient Data
No. of Patients 18
Male/female 17/1
Age (yrs) 65 6 5 (59–79)
LVEF (%) 19 6 4.5 (10–27)
LVEDD (mm) 74.1 6 6.2 (68–90)
PR interval (ms) 221 6 52 (170–280)
QRS (ms) 170 6 37 (120–220)
Idiopathic/ischemic/others 14/2/2
NYHA class
III 4
IV 14
Diuretics 18
ACE inhibitors 18
Digoxin 11
LVEDD 5 left ventricular end diastolic diameter; LVEF 5 left ventricular
ejection fraction.
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Biventricular-DDD pacing versus baseline (AAI mode)
(Tables 2 and 3). Comparing the “optimal” biventricular
DDD pacing mode with baseline (AAI pacing) in each patient
revealed a highly significant benefit in terms of cardiac output
increase (2.7 6 0.7 vs. 2 6 0.4 l/mn/m2, 135%; p , 0.001) and
of mean PCWP, with a mean decrease of 18.5% (22 6 8 vs.
27 6 9 mm Hg; p , 0.001). The V-wave was also significantly
reduced in biventricular pacing mode with a mean value of
21% (26 6 10 vs. 33 6 11 mm Hg; p , 0.001) (Fig. 3).
Biventricular DDD pacing versus conventional RV DDD
pacing (Tables 2 and 3). Comparing the hemodynamic effects
of “conventional” DDD RV single-site and biventricular DDD
pacing modes elicited interesting results, including a slight but
statistically significant (p , 0.01) improvement of CI
(112.5%), mean PCWP (29%) and V-wave (29%).
Responder versus nonresponder patients. Responder pa-
tients were defined as patients in which CI increased by 10% or
more and PCWP decreased by 10% or more with biventricular
DDD pacing compared to baseline (AAI mode). According to
this definition, 12 patients were responder and 6 were nonre-
sponders. From the different parameters studied (Table 4),
univariate analysis showed that the only predictive factor of
hemodynamic improvement was baseline LV ejection fraction.
The LVEF was significantly lower in responder as compared to
nonresponder patients (17 6 27% vs. 21.6 6 5.8%; p 5 0.036).
In contrast, PR interval, QRS duration and the presence of left
axis deviation had no predictive value.
Discussion
Our study was aimed at assessing the acute hemodynamic
effects of the best mode of DDD pacing therapy in patients
with chronic CHF. Simultaneous biatrial pacing and simulta-
neous biventricular pacing with an “optimal” AV delay in each
patient were expected to optimize AV synchrony in the left
heart as well as the ventricular activation sequence. The results
of that method appeared to be positive because under the best
pacing configuration for each individual patient, biventricular
DDD pacing increased cardiac output by 35% (p , 0.001) on
average, relative to AAI pacing, and by 12.5% relative to
“optimal” RV single-site DDD pacing (p , 0.01). Mean and
peak PCWP decreased on average by 18.5% (p , 0.001) and
21% (p , 0.001), respectively, relative to AAI pacing. How-
ever, response to pacing still varies much between patients.
Twelve of the 18 patients can be considered as good respond-
ers when defined as an increase in cardiac output and PCWP
reduction by more than 10%. Six patients—one-third of the
population studied—were not improved. Thus, this prelimi-
nary study did not identify any predictive criteria of the type of
response to biventricular DDD pacing, except that the LVEF
was significantly lower (p , 0.04) in responders than in
Table 2. Hemodynamic and Electrophysiologic Data With the Three Pacing Modes Tested
AAI DDD RV DDD biventricular
AAI vs. DDD RV AAI vs. BIV DDD DDD RV BIV DDD
p
PR/AVD (ms) 221 6 52 114 6 30 110 6 29 ** ** NS
QRS (ms) 170 6 37 200 6 22 154 6 18 ** ** NS
Axis (0) 215 6 43 43 6 82 50 6 67 ** ** NS
HR (bpm) 77 6 15 78 6 15 78 6 14 NS NS NS
SBP (mm Hg) 115 6 10 122 6 6 127 6 15 NS NS NS
DBP (mm Hg) 68 6 12 75 6 16 80 6 18 NS NS NS
MBP (mm Hg) 80 6 7 77 6 5 77 6 4 NS NS NS
SPAP (mm Hg) 62 6 21 60 6 20 57 6 17 NS NS NS
D PAP (mm Hg) 28 6 9 28 6 8 27 6 9 NS NS NS
M PAP (mm Hg) 40 6 11 40 6 11 38 6 11 NS NS NS
V-wave (mm Hg) 32 6 11 29 6 11 26 6 10 ** *** *
Mean PCWP (mm Hg) 27 6 9 24 6 8 22 6 9 ** *** *
CI (l/min/m2) 2 6 0.4 2.4 6 0.6 2.7 6 0.7 ** *** **
AVD 5 AV delay; BP 5 blood pressure; CI 5 cardiac index; D 5 diastolic; HR 5 heart rate; M 5 mean; PAP 5 pulmonary artery pressure; PCWP 5 pulmonary
capillary wedge pressure; S 5 systolic. *p , 0.05; **p , 0.01; ***p , 0.001.
Figure 2. Surface ECG (25 mm/s) showing the effects on QRS
duration of switching from the AAI pacing mode (left side) to the
biventricular DDD pacing mode (right side) at the same pacing rate.
QRS duration is decreased by 110 ms (240 to 130 ms).
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nonresponders. There was a trend toward a longer mean PR
interval and QRS duration in responders, although the differ-
ence was not statistically significant.
Previous experience with conventional DDD pacing in
CHF. Short-term studies conducted in the early 1990s sug-
gested that patients in normal sinus rhythm with severe CHF
related to chronic LV systolic dysfunction and without any
conventional indication for permanent cardiac pacing could
benefit from DDD pacing with short AV delay programming
(2,7), their symptoms and LVEF being significantly improved.
The ventricular lead was conventionally placed at the RV apex
(RVA). This beneficial effect was primarily attributed to the
optimization of LV filling by significant prolongation of the
ventricular filling time and reduction of presystolic mitral
regurgitation (8). The study by Nishimura et al. (6), however,
showed that DDD pacing could significantly improve cardiac
performance only in patients with a long PR interval on surface
ECG and evidence of major AV dysynchrony in the left heart.
Responder patients were also characterized by a very short LV
filling time and a long duration of mitral regurgitation in
spontaneous rhythm. These preliminary data were only fo-
cused on the effect of DDD pacing on AV synchrony. At that
time the general view was that the potential detrimental effects
of ventricular pacing at the RVA on LV function (9,10) were
largely counterbalanced by the benefits of extended filling time
(8). However, the interest for conventional short AV delay
DDD pacing was quickly damped by results from prospective
studies, either controlled or uncontrolled, showing no im-
provement or even deterioration with pacing (4,5).
Figure 3. Acute hemodynamic effects of temporary biventricular DDD
pacing in a class III patient with ischemic cardiomyopathy. Switching
from AAI to biventricular DDD pacing at the same pacing rate
produces an instantaneous decrease in pulmonary capillary wedge
pressure (PCWP) (mean and systolic peak) and a 32% increase in
cardiac output, while the QRS duration is decreased by 35% (200 to
130 ms).
Table 3. Individual Hemodynamic Data in the Different Pacing Modes (AAI, DDD RVA, DDD RVOT, DDD Biventricular)
Patient
AAI DDD RVA DDD RVOT BIV
CI
(l/mn/n2)
mPCWP
(mm Hg)
V-Wave
(mm Hg)
CI
(l/mn/m2)
mPCWP
(mm Hg)
V-Wave
(mm Hg)
CI
(l/mn/m2)
mPCWP
(mm Hg)
V-Wave
(mm Hg)
CI
(l/mn/m2)
mPCWP
(mm Hg)
V-Wave
(mm Hg)
1 2.34 35 40 2.66 35 45 2.2 35 40 3.75 35 40
2 2 40 40 2 40 40 2 43 43 2.26 40 40
3 2.48 11 11 3.47 11 11 2.9 12 12 3.15 13 13
4 1.56 34 41 1 31 39 1 30 39 1.6 27 32
5 1.73 22 33 1.77 36 43 1.79 30 40 1.78 20 30
6 1.75 31 45 2.33 28 33 — — — 2.56 28 32
7 2.3 19 20 2.39 10 10 2.62 19 20 2.67 17 17
8 1.75 27 35 2.15 26 30 2.3 25 30 2.3 18 24
9 1.75 37 45 — — — 2.13 25 35 2.1 26 30
10 1.9 14 16 2.45 12 18 2.75 14 16 3 9 12
11 1.8 37 39 1.95 38 40 2.4 32 35 2.3 32 35
12 2.65 20 25 2.95 20 35 3.2 21 27 3.5 13 20
13 2.1 20 24 2.2 22 26 2.2 18 25 3.1 12 15
14 1.7 22 30 1.6 25 32 2.2 25 30 2.35 18 25
15 2.5 30 35 3 30 40 2.56 30 35 3.2 25 27
16 1.6 28 40 — — — 1.7 25 30 2 22 30
17 2.15 38 45 2.4 33 40 2.4 33 40 2.7 32 40
18 2.9 16 20 2.65 20 25 3.17 20 25 3.65 14 18
CI 5 Cardiac index; mPCWP 5 mean pulmonary capillary wedge pressure; RVA 5 right ventricular apex; RVOT 5 right ventricular outflow tract; BIV 5
biventricular.
Table 4. Comparison of Responder and Nonresponder Patients
Responders
(n 5 12)
Nonresponders
(n 5 6) p
QRS ms 175 6 33 163 6 44 0.5
PR ms 234 6 44 220 6 38 0.5
Axis0 220 6 36 230 6 56 0.6
LEVF % 17 6 2.7 21.6 6 5.8 0.036
LVEF 5 Left ventricular ejection fraction.
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Alternative ventricular pacing sites. Further studies as-
sessed the potential interest of improving both the AV syn-
chrony and the activation sequence of the paced ventricle. A
first attempt in this direction consisted in pacing the right
ventricle at alternative sites, especially the RV outflow tract
(RVOT) or the septal wall. Cowell et al. (11) studied the acute
hemodynamic effects of (DDD) pacing at two different sites in
RV, the apex and the septum close to the His bundle area in 15
patients with normal sinus rhythm and chronic CHF associated
with poor LV function. Cardiac output increased significantly
with RV septal DDD pacing in comparison to no pacing (4.9 6
8 l/mn vs. 4.1 6 7 l/mn; p , 0.04), but the difference was not
statistically significant when compared with RV apical DDD
pacing (4.4 6 7 l/mn; p 5 NS). This trend toward better cardiac
performance with RV septal DDD pacing was not confirmed
by a recently published cross-over randomized study by Gold et
al. (12), who compared the hemodynamic effects of temporary
RV septal (or RVOT) DDD pacing with spontaneous sinus
rhythm in 13 CHF patients. Overall, pacing did not signifi-
cantly improve cardiac output and right heart pressures. Sub-
group analysis did not reveal any influence of the etiology of
LV dysfunction, either idiopathic or ischemic, nor of the
presence of a long PR interval on results.
Rationale for multisite pacing in CHF. In our study we
deliberately selected patients with major intraventricular con-
duction block in spontaneous sinus rhythm. This type of
abnormality is common in patients with dilated cardiomyopa-
thy, either idiopathic or of ischemic origin. In Wilensky’s study
(13), 82% of patients had significant intraventricular conduc-
tion disturbances on the last ECG recorded within 60 days
before death. Among the patients who presented with conduc-
tion abnormalities at baseline, 68% had progressive distur-
bances in the time period studied. The mean QRS duration
increased from 100 6 20 ms at the first examination to 130 6
30 ms at the end of follow-up. But very long QRS duration can
occur, as in our series. Complete bundle branch block (BBB)
was seen in 38% of patients, principally left BBB (29%). Right
BBB was rare (9%) but was associated with left axis deviation
in two-third of cases, indicating a probable association with left
anterior fascicular block. Overall, left QRS axis deviation
greater than 230° was observed in 65% of patients in the
group.
The hemodynamic consequences of abnormal ventricular
activation in DCM patients were extensively studied by Xiao et
al. (14–16), who analyzed, using continuous-wave Doppler, the
characteristics of the LV pressure pulse derived from the time
course of functional mitral regurgitation. In 50 DCM patients
with QRS duration between normal and extremely long
(190 ms) and averaging 110 ms, a positive correlation was
found between the QRS duration and the overall duration of
mitral regurgitation LV contraction time (the time interval
from Q to peak pressure), and to peak 1dP/dt, and negatively
with the peak rate of rise in LV pressure. These data show that
the wider is the QRS complex, the longer are the LV contrac-
tion and relaxation times and poorer the LV systolic perfor-
mance. Furthermore, prolonged isovolumic contraction and
relaxation times induced a proportionate decrease in LV filling
time to a critical value of 200 ms or less in patients with the
longest QRS duration. The morphology (right or left BBB, or
indefinite intraventricular conduction block) and axis of the
QRS complex seem to have no direct influence on the magni-
tude of the abnormalities observed. However, Xiao et al. (14)
noted that left axis deviation was associated with the longest
QRS duration and thus with more severe electromechanical
alterations. All these observations account for the presence of
major delay and uneven contraction and relaxation in patients
with poor LV function and a high degree conduction block
within the ventricle.
Right ventricular pacing enhances such asynchrony and
thus delays LV activation. These effects are all the more
important as cardiac function is altered. Endocardial mapping
studies (17,18) have shown that the earliest local activation
time, the total LV endocardial activation time and the total
duration of LV electrical activity were significantly longer in
patients with structural heart disease than in those with a
normal heart and that the greater values were noted in patients
with coronary artery disease with previous infarction scars.
These studies have also shown that except in the patient
subgroup with previous septal scars, the site of the latest LV
activation during RV apical pacing was the LV posterior or
posteroinferior base in the vast majority of patients with
chronic LV dysfunction (Fig. 4). This explains why we chose to
pace the left ventricle at its posterior base by placing the lead
at the ostium of a lateral or posterolateral vein of the left
ventricle in our series, which included a vast majority of
idiopathic dilated cardiomyopathies. The aim was to simulta-
neously pace the two ventricles at the sites of the earliest
activation in the right ventricle and of the latest activation in
the left ventricle, thus expecting to best correct the activation
and contraction asynchrony. This objective of optimal ventric-
ular resynchronization is the rationale for treating heart failure
by simultaneous biventricular pacing in patients with major
Figure 4. Intracardiac ECG recording at the sites of the earliest
(inferior base of the right ventricle close to the tricuspid annulus) and
of the latest ventricular activation (posterolateral base of the left
ventricle). The interventricular conduction delay is 190 ms.
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intraventricular conduction block. The significant reduction of
QRS duration observed in this study under both biventricular
DDD pacing modes, as compared with the two single-site
RV-DDD and AAI pacing, bolstered the hypothesis that LV
activity was resynchronized. The issue is to establish whether
this partial correction of ventricular activation asynchrony is
accompanied by an improvement of cardiac performance or
not.
Acute hemodynamic effects of biventricular pacing. The
first hemodynamic study on the acute effects of biventricular
pacing did not address heart failure but rather the immediate
postoperative consequences of aortocoronary bypass graft
(19). In the study by Foster (19), four different pacing modes
were randomly tested in 18 patients with LVEF .40%: AAI,
RV-DDD, LV-DDD and biventricular DDD. Epicardial leads
were set on the anterior face of both ventricles either side of
the septum. Results showed a significant increase in cardiac
output and a significant decrease in systemic vascular resis-
tances under biventricular DDD pacing in comparison to other
pacing modes.
These results are in agreement with those of our own study
in CHF patients, but they partially differ from the recent report
by Blanc et al. (20), who compared the acute hemodynamic
effects of single-site RV pacing at the apex, of single site LV
pacing, of simultaneous biventricular pacing and of intrinsic
conduction in 23 patients with severe heart failure. Both LV
pacing and biventricular pacing produced a significant de-
crease in PAP and PCWP, and a significant increase in arterial
pressure. Cardiac output was not monitored in this study.
Blanc et al. (20) did not find any significant difference between
LV pacing alone and biventricular pacing. We can note that in
the Blanc study, the LV was paced endocardially, whereas in
our study the LV was paced epicardially at the posterolateral
base corresponding to the site of latest LV activation. We can
presume that these two approaches may result in different
electrophysiologic and hemodynamic effects.
Study limitations. One of the limitations of our study is
that biventricular pacing was acutely tested and we cannot
predict the long-term response of chronic biventricular pacing.
Furthermore, this study did not provide answers to a number
of other questions: What are the underlying mechanisms of
that beneficial hemodynamic effect? What is the optimal
configuration to pace both ventricles? Additional studies using
the most adequate imaging techniques are needed.
Conclusions. This acute study demonstrated that, com-
pared with intrinsic rhythm and single-site RVDDD pacing,
biventricular DDD pacing may significantly improve cardiac
performance in patients with major intraventricular conduc-
tion block and severe CHF related to chronic LV dysfunction.
Such encouraging results, adding to those of the first attempts
at permanent pacing (21,22) in patients with chronic heart
failure, are an encouragement to initiate controlled studies to
validate that novel therapeutic method.
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